Abstract: The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neutron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Type:
Application
Filed:
May 20, 2002
Publication date:
March 13, 2003
Applicant:
The Speywood Laboratory Ltd.
Inventors:
Keith Alan Foster, Michael John Duggan, Clifford Charles Shone
Abstract: The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neuron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Type:
Grant
Filed:
November 22, 1999
Date of Patent:
May 28, 2002
Assignees:
The Speywood Laboratory, Ltd., Microbiological Research Authority
Inventors:
Keith Alan Foster, Michael John Duggan, Clifford Charles Shone
Abstract: The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neuron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Type:
Grant
Filed:
January 12, 1998
Date of Patent:
November 23, 1999
Assignees:
The Speywood Laboratory Ltd., Microbiological Research Authority
Inventors:
Keith Alan Foster, Michael John Duggan, Clifford Charles Shone
© 2024 Justia
